3-n-methylspiperone has been researched along with dizocilpine maleate in 1 studies
| Studies (3-n-methylspiperone) | Trials (3-n-methylspiperone) | Recent Studies (post-2010) (3-n-methylspiperone) | Studies (dizocilpine maleate) | Trials (dizocilpine maleate) | Recent Studies (post-2010) (dizocilpine maleate) |
|---|---|---|---|---|---|
| 155 | 6 | 7 | 7,741 | 9 | 1,449 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gee, A; Inoue, O; Kobayashi, K; Wakahara, S | 1 |
1 other study(ies) available for 3-n-methylspiperone and dizocilpine maleate
| Article | Year |
|---|---|
Enhancement of 3H-N-methylspiperone binding but not 3H-raclopride binding in mouse striatum by MK-801: evidence that factors other than competition by endogenous dopamine are responsible for changes in D2 receptor binding in vivo. Short communication.
Topics: Animals; Binding Sites; Cerebellum; Cerebral Cortex; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Antagonists; Kinetics; Mice; Models, Biological; Neostriatum; Raclopride; Receptors, Dopamine D2; Salicylamides; Spiperone | 1999 |